MP
COCHW icon

Mangrove Partners’s Envoy Medical Warrant COCHW Stock Holding History

Mangrove Partners’s Portfolio COCHW Stock Details COCHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,143
Closed -$112K – 253
2022
Q4 		$112K Hold
11,143
– – 0.01% 331
2022
Q3 		$109K Buy
+11,143
New +$1.01K 0.01% 350

Other funds holding COCHW

BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
AC
Athos Capital Hong Kong $282M AUM 11.4% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Mangrove Partners's COCHW Position: Q1 2023 in Review

Mangrove Partners sold out of Envoy Medical Warrant (COCHW) in Q1 2023, closing a stake of 11,143 shares — an estimated $112K sold.

Mangrove Partners first reported a position in COCHW in Q3 2022 and held it in 2 quarters. The position peaked at $112K in Q4 2022. 62 funds tracked by Wall St. Rank hold COCHW as of Q1 2023.

  • Mangrove Partners reported no remaining Envoy Medical Warrant position as of Q1 2023 after selling out during the quarter.
  • Mangrove Partners sold 11,143 Envoy Medical Warrant shares in Q1 2023, an estimated $112K.
  • Mangrove Partners first reported a position in Envoy Medical Warrant in Q3 2022 and held it in 2 quarters.
  • Mangrove Partners's Envoy Medical Warrant position peaked at $112K in Q4 2022.
  • 62 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2023.

Based on Mangrove Partners's 13F filing for Q1 2023, filed 15 May 2023.